The Oncology Institute, Inc.
TOI
$3.78
$0.020.53%
NASDAQ
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 13.99% | 14.75% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 13.99% | 14.75% | |||
| Cost of Revenue | 15.00% | 17.38% | |||
| Gross Profit | 8.11% | 1.46% | |||
| SG&A Expenses | -6.15% | 6.03% | |||
| Depreciation & Amortization | -4.54% | 1.18% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 10.38% | 14.61% | |||
| Operating Income | 28.16% | -13.12% | |||
| Income Before Tax | 3.71% | 12.48% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 2.97% | 13.15% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 2.97% | 13.15% | |||
| EBIT | 28.16% | -13.12% | |||
| EBITDA | 32.69% | -15.74% | |||
| EPS Basic | 5.86% | 28.01% | |||
| Normalized Basic EPS | 7.92% | 11.82% | |||
| EPS Diluted | 5.86% | 28.52% | |||
| Normalized Diluted EPS | 7.92% | 11.82% | |||
| Average Basic Shares Outstanding | 4.58% | 20.89% | |||
| Average Diluted Shares Outstanding | 4.58% | 20.89% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||